Department of Radiation Oncology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA.
Int J Gynecol Cancer. 2022 Mar;32(3):446-450. doi: 10.1136/ijgc-2021-003039.
The COVID-19 pandemic has forever affected healthcare and posed an incredible challenge to our society to care for our sick. Patients with cancer were found early on to have higher rates of complications with COVID-19. Radiation therapy is an integral part of treatment for many types of gynecologic cancer and adaptation on its utilization during the pandemic varied across the globe. In this review, we detail certain guidelines for the use of radiation in gynecologic cancers during the pandemic as well as real world accounts of how different countries adapted to these guidelines or created their own based on individualized resources, staffing, government restrictions, and societal norms. Critically, this review demonstrates the breadth of fractionation schemes and technologies used when resources were limited but highlights the importance of long term follow-up for many of our patients during this time.
COVID-19 大流行永远地影响了医疗保健行业，并对我们的社会照顾病人的能力提出了难以置信的挑战。人们很早就发现，癌症患者感染 COVID-19 的并发症发生率更高。放射治疗是许多妇科癌症治疗的重要组成部分，在全球范围内，其在大流行期间的使用方式也各不相同。在这篇综述中，我们详细介绍了大流行期间妇科癌症中放射治疗的某些使用指南，以及不同国家如何根据个体化资源、人员配备、政府限制和社会规范来适应这些指南或制定自己的指南的实际情况。至关重要的是，这篇综述展示了在资源有限的情况下使用的分割方案和技术的多样性，但也强调了在此期间对我们许多患者进行长期随访的重要性。
